Personal information

Countries

Spain

Activities

Collapse all

Employment (1)

Vall d’Hebron Hospital Universitari: Barcelona, Catalunya, ES

MD (Infectious Diseases)
Employment
Source: Self-asserted source
Júlia Sellarès-Nadal

Education and qualifications (2)

Vall d’Hebron Hospital Universitari: Barcelona, Catalunya, ES

2016-05-01 to 2021-06-01 | Residency (Internal Medicine)
Education
Source: Self-asserted source
Júlia Sellarès-Nadal

Universitat Autònoma de Barcelona: Barcelona, Barcelona, ES

2009-09-01 to 2015-06-01 | Llicenciatura en Medicina
Education
Source: Self-asserted source
Júlia Sellarès-Nadal

Works (12)

Correction: Kirkegaard-Biosca et al. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria. Antibiotics 2024, 13, 874

Antibiotics
2024-12-24 | Journal article
DOI: 10.3390/antibiotics14010004
Contributors: Cristina Kirkegaard-Biosca; Ester del Barrio-Tofiño; Miguel Villamarín; Nieves Larrosa; David Campany; Juan José González-López; Ricard Ferrer; Belén Viñado; Laura Doménech; Julia Sellarès-Nadal et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Impact of viral detection in patients with community-acquired pneumonia: An observational cohort study

Medicina Clínica
2023-12 | Journal article
DOI: 10.1016/j.medcli.2023.07.018
Contributors: Julia Sellarès-Nadal; Joaquin Burgos; Fernando Velasquez; Maria Teresa Martin-Gómez; Andrés Antón; Dani Romero-Herrera; Simeón Eremiev; Pau Bosch-Nicolau; Dolors Rodriguez-Pardo; Oscar Len et al.
Source: check_circle
Crossref

Impact of viral detection in patients with community-acquired pneumonia: An observational cohort study

Medicina Clínica (English Edition)
2023-12 | Journal article
DOI: 10.1016/j.medcle.2023.07.013
Contributors: Julia Sellarès-Nadal; Joaquin Burgos; Fernando Velasquez; Maria Teresa Martin-Gómez; Andrés Antón; Dani Romero-Herrera; Simeón Eremiev; Pau Bosch-Nicolau; Dolors Rodriguez-Pardo; Oscar Len et al.
Source: check_circle
Crossref

<i>Cutibacterium</i> spp. Infections after Instrumented Spine Surgery Have a Good Prognosis Regardless of Rifampin Use: A Cross-Sectional Study

Antibiotics
2023-03 | Journal article | Author
DOI: 10.3390/antibiotics12030518
Contributors: Susana Núñez-Pereira; Eva Benavent; Marta Ulldemolins; Beatriz Sobrino-Díaz; José A. Iribarren; Rosa Escudero-Sánchez; María Dolores del Toro López; Andrés Nodar; Luisa Sorli; Alberto Bahamonde et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Community-acquired pneumonia in hospitalised patients: changes in aetiology, clinical presentation, and severity outcomes in a 10-year period

Annals of Medicine
2022-12-31 | Journal article
DOI: 10.1080/07853890.2022.2138529
Contributors: Júlia Sellarès-Nadal; Joaquín Burgos; María Teresa Martín-Gómez; Andrés Antón; Roger Sordé; Daniel Romero-Herrero; Pau Bosch-Nicolau; Anna Falcó-Roget; Cristina Kirkegaard; Dolors Rodríguez-Pardo et al.
Source: check_circle
Crossref

Low frequency of cytomegalovirus (CMV) disease despite high prevalence of CMV viraemia in patients with advanced HIV infection: a clinical and immunological 48‐week follow‐up study

HIV Medicine
2021-09 | Journal article
DOI: 10.1111/hiv.13115
Contributors: A Albasanz‐Puig; P Suanzes; J Esperalba; C Fernández; J Sellarès‐Nadal; A Torrella; B Planas; A Segura; J Burgos; E Ribera et al.
Source: check_circle
Crossref

Incidence and risk factors for early readmission after hospitalization for SARS-CoV-2 infection: results from a retrospective cohort study

Infection
2021-07-30 | Journal article
DOI: 10.1007/s15010-021-01662-1
Part of ISSN: 0300-8126
Part of ISSN: 1439-0973
Source: Self-asserted source
Júlia Sellarès-Nadal

Early outcomes in adults hospitalized with severe SARS-CoV-2 infection receiving tocilizumab

Medicina Clínica
2021-06 | Journal article
DOI: 10.1016/j.medcli.2021.06.012
Part of ISSN: 0025-7753
Source: Self-asserted source
Júlia Sellarès-Nadal

An Overview of Cilastatin + Imipenem + Relebactam as a Therapeutic Option for Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia: Evidence to Date

Expert Opinion on Pharmacotherapy
2021-06-12 | Journal article
DOI: 10.1080/14656566.2021.1939680
Part of ISSN: 1465-6566
Part of ISSN: 1744-7666
Source: Self-asserted source
Júlia Sellarès-Nadal

Periprosthetic Joint Infection Prophylaxis in the Elderly after Hip Hemiarthroplasty in Proximal Femur Fractures: Insights and Challenges

Antibiotics
2021-04-13 | Journal article
DOI: 10.3390/antibiotics10040429
Contributors: Dolors Rodríguez-Pardo; Laura Escolà-Vergé; Júlia Sellarès-Nadal; Pablo S. Corona; Benito Almirante; Carles Pigrau
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

<p>Investigational and Experimental Drugs for Community-Acquired Pneumonia: the Current Evidence</p>

Journal of Experimental Pharmacology
2020-11 | Journal article
DOI: 10.2147/jep.s259286
Part of ISSN: 1179-1454
Source: Self-asserted source
Júlia Sellarès-Nadal
grade
Preferred source (of 2)‎

Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

Clinical Microbiology and Infection
2020-11 | Journal article
DOI: 10.1016/j.cmi.2020.07.024
Part of ISSN: 1198-743X
Source: Self-asserted source
Júlia Sellarès-Nadal

Peer review (1 review for 1 publication/grant)

Review activity for Open forum infectious diseases. (1)
How many people are using ORCID?